Page 1710 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

the four-year experience of a level I trauma center. J Trauma. 77. Hurlbert RJ, Hamilton MG. Methylprednisolone for acute spi-
May 2008;64(5):1258-1263. nal cord injury: 5-year practice reversal. Can J Neurol Sci. March
62. Dunham CM, Brocker BP, Collier BD, Gemmel DJ. Risks asso- 2008;35(1):41-45.
ciated with magnetic resonance imaging and cervical collar in 78. Hagen EM, Faerestrand S, Hoff JM, Rekand T, Gronning M.
comatose, blunt trauma patients with negative comprehensive Cardiovascular and urological dysfunction in spinal cord injury.
cervical spine computed tomography and no apparent spinal Acta Neurol Scand Suppl. 2011(191):71-78.
deficit. Crit Care. 2008;12(4):R89. 79. Dietrich WD, Cappuccino A, Cappuccino H. Systemic hypo-
63. Hennessy D, Widder S, Zygun D, Hurlbert RJ, Burrowes P, thermia for the treatment of acute cervical spinal cord injury
Kortbeek JB. Cervical spine clearance in obtunded blunt trauma in sports. Curr Sports Med Rep. January-February 2011;10(1):
patients: a prospective study. J Trauma. March 2010;68(3): 50-54.
576-582. 80. Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit
64. Panczykowski DM, Tomycz ND, Okonkwo DO. Comparative Care. August 2001;7(4):221-226.
effectiveness of using computed tomography alone to exclude 81. Terao Y, Ichinomiya T, Higashijima U, et al. Comparison
cervical spine injuries in obtunded or intubated patients: meta- between propofol and dexmedetomidine in postoperative seda-
analysis of 14,327 patients with blunt trauma. J Neurosurg. tion after extensive cervical spine surgery. J Anesth. 2012;
September 2011;115(3):541-549. 26(2):179-186.
65. Traynelis VC, Kasliwal MK. Cervical clearance. J Neurosurg. 82. Rodriguez DJ, Benzel EC, Clevenger FW. The metabolic response
September 2011;115(3):536-539; discussion 539-540. to spinal cord injury. Spinal Cord. September 1997;35(9):
66. Nesathurai S. Steroids and spinal cord injury: revisiting 599-604.
the NASCIS 2 and NASCIS 3 trials. J Trauma. December 83. Thibault-Halman G, Casha S, Singer S, Christie S. Acute
1998;45(6):1088-1093. management of nutritional demands after spinal cord injury.
67. Pharmacological therapy after acute cervical spinal cord injury. J Neurotrauma. August 2011;28(8):1497-1507.
Neurosurgery. March 2002;50(suppl 3):S63-S72. 84. Wong S, Derry F, Jamous A, Hirani SP, Grimble G, Forbes A.
68. Geisler FH, Coleman WP, Grieco G, Poonian D. The Sygen mul- The prevalence of malnutrition in spinal cord injuries patients:
ticenter acute spinal cord injury study. Spine (Phila Pa 1976). a UK multicentre study. Br J Nutr. December 15, 2011:1-6.
December 15, 2001;26(suppl 24):S87-S98. 85. Godoy DA, Di Napoli M, Rabinstein AA. Treating hyperglyce-
69. Geisler FH, Dorsey FC, Coleman WP. Recovery of motor mia in neurocritical patients: benefits and perils. Neurocrit Care.
function after spinal-cord injury—a randomized, placebo- December 2010;13(3):425-438.
controlled trial with GM-1 ganglioside. N Engl J Med. June 27, 86. Halpern NA, Hale KE, Sepkowitz KA, Pastores SM. A world
1991;324(26):1829-1838. without ventilator-associated pneumonia: time to abandon sur-
70. Baptiste DC, Fehlings MG. Pharmacological approaches to veillance and deconstruct the bundle. Crit Care Med. January
repair the injured spinal cord. J Neurotrauma. March-April 2012;40(1):267-270.
2006;23(3-4):318-334. 87. Nie H, Jiang D, Ou Y, et al. Procalcitonin as an early predictor
71. Gogel S, Gubernator M, Minger SL. Progress and prospects: of postoperative infectious complications in patients with acute
stem cells and neurological diseases. Gene Ther. January traumatic spinal cord injury. Spinal Cord. June 2011;49(6):
2011;18(1):1-6. 715-720.
72. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of meth- 88. Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle
ylprednisolone in acute spinal cord injury. JAMA. January 6, P. Prevention of venous thromboembolism after injury: an
1984;251(1):45-52. evidence-based report—part II: analysis of risk factors and
73. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, evaluation of the role of vena caval filters. J Trauma. July
controlled trial of methylprednisolone or naloxone in the 2000;49(1):140-144.
treatment of acute spinal-cord injury. Results of the Second 89. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in
National Acute Spinal Cord Injury Study. N Engl J Med. May 17, nonorthopedic surgical patients: Antithrombotic Therapy and
1990;322(20):1405-1411. Prevention of Thrombosis, 9th ed: American College of Chest
74. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylpredni- Physicians Evidence-Based Clinical Practice Guidelines. Chest.
solone or naloxone treatment after acute spinal cord injury: February 2012;141(suppl 2):e227S-e277S.
1-year follow-up data. Results of the second National Acute 90. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous
Spinal Cord Injury Study. J Neurosurg. January 1992;76(1):23-31. thromboembolism: American College of Chest Physicians
75. Bracken MB, Shepard MJ, Holford TR, et al. Administration of Evidence-Based Clinical Practice Guidelines (8th Edition).
methylprednisolone for 24 or 48 hours or tirilazad mesylate for Chest. June 2008;133(suppl 6):381S-453S.
48 hours in the treatment of acute spinal cord injury. Results 91. Green D, Rossi EC, Yao JS, Flinn WR, Spies SM. Deep vein
of the Third National Acute Spinal Cord Injury Randomized thrombosis in spinal cord injury: effect of prophylaxis with calf
Controlled Trial. National Acute Spinal Cord Injury Study. compression, aspirin, and dipyridamole. Paraplegia. August
JAMA. May 28 1997;277(20):1597-1604. 1982;20(4):227-234.
76. Hurlbert RJ. The role of steroids in acute spinal cord injury: an 92. Clinical practice guidelines: Neurogenic bowel manage-
evidence-based analysis. Spine (Phila Pa 1976). December 15, ment in adults with spinal cord injury. Spinal Cord Medicine
2001;26(suppl 24):S39-S46. Consortium. J Spinal Cord Med. July 1998;21(3):248-293.

Section10-O-Ref.indd 3 1/21/2015 11:30:13 AM